Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Assembly Biosciences
Assembly Biosciences
Hepatitis B drug developers chart slow progress forward, just like hep C before it
Fierce Biotech
Tue, 11/14/23 - 09:35 am
hepatitis B
hepatitis C
drug development
Assembly Biosciences
GSK
Aligos Therapeutics
Gilead pays $100M for first dibs on all Assembly Bio assets, bolting antiviral engine to its R&D group
Fierce Biotech
Tue, 10/17/23 - 10:27 am
Gilead Sciences
Assembly Biosciences
antivirals
hepatitis B
Emerging from hepatitis B flops, Assembly Bio showcases early data on next-gen drugs
Endpoints
Mon, 12/19/22 - 12:13 pm
Assembly Biosciences
John McHutchison
hepatitis B
ABI-H3733
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
layoffs
hirings
Astellas
Pfizer
Eikon Therapeutics
Bayer
Avadel Pharma
Heron Therapeutics
Adverum Biotechnologies
Biogen
Eisai
X4 Pharmaceuticals
Assembly Biosciences
Assembly Bio scraps hepatitis B drug, cuts staff after clinical setback
BioPharma Dive
Thu, 07/21/22 - 09:54 pm
Assembly Biosciences
hepatitis B
layoffs
vebicorvir
Key data catalysts for the industry’s small players
EP Vantage
Fri, 07/1/22 - 09:35 am
Intercept Pharma
Akero
NASH
Kymera
atopic dermatitis
Zealand Pharma
short bowel syndrome
Relmada
Verona
Anavex
Assembly Biosciences
Aldeyra
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
Fierce Biotech
Wed, 05/25/22 - 10:34 am
Antios
hepatitis B
Assembly Biosciences
FDA
Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling
Endpoints
Sat, 11/7/20 - 11:06 pm
Assembly Biosciences
hepatitis B
clinical trials
vebicorvir
EASL 2020 – Assembly finds a partner as hepatitis B inches forward
EP Vantage
Fri, 08/28/20 - 10:34 am
EASL
RNAi
hepatitis B
Assembly Biosciences
Abrutus
JNJ
GSK
Vir Biotechnology
BeiGene expands pipeline and hops on board a quest to cure hep B, inking a $540M deal with a fellow upstart biotech
Endpoints
Mon, 07/20/20 - 10:29 am
China
BeiGene
Assembly Biosciences
hepatitis B
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Fierce Biotech
Fri, 06/19/20 - 11:24 am
Assembly Biosciences
microbiome
Allergan
AbbVie
M&A
Here's Why Assembly Biosciences Stock Is Soaring Today
Motley Fool
Thu, 12/12/19 - 05:28 pm
Assembly Biosciences
AASLD 2019 – Assembly asks investors to keep the faith
EP Vantage
Thu, 11/14/19 - 10:15 am
AASLD
Assembly Biosciences
hepatitis B
ABI-H0731
3 Things to Watch From the Pharmaceutical Industry's Liver Meeting
Motley Fool
Wed, 10/23/19 - 10:40 am
liver disease
NASH
The Liver Meeting
Assembly Biosciences
CymaBay Therapeutics
Madrigal Pharmaceuticals
Microbiome Report for Week Ending 5/4/19
CP Wire
Fri, 05/10/19 - 10:45 am
microbiome
Synlogic
Axial Biotherapeutics
asd
autism
Assembly Biosciences
Microbiome Report for Week Ending 4/20/19
CP Wire
Fri, 04/26/19 - 11:35 am
microbiome
AOBiome
Assembly Biosciences
Microbiome Report for Week Ending 4/20/19
Fri, 04/26/19 - 11:14 am
microbiome
AOBiome
Assembly Biosciences
Microbiome report week ending 7-14-18
CP Wire
Tue, 07/17/18 - 09:38 am
microbiome
Assembly Biosciences
autism
Diversigen
Norgen Biotek
Microbiome report week ending 7-14-18
Tue, 07/17/18 - 09:36 am
microbiome
Assembly Biosciences
autism
Diversigen
Norgen Biotek